Spangler D L, Vanderpool G E, Carroll M S, Tinkelman D G
Ann Allergy. 1980 Oct;45(4):246-7.
Eighteen patients with chronic urticaria were evaluated concerning the benefit of oral sympathomimetic therapy. No significant differences could be found between the sympathomimetic agent (terbutaline) and a placebo in the various clinical parameters evaluated. The authors conclude that the efficacy of this drug is doubtful in the treatment of chronic urticaria.
对18例慢性荨麻疹患者进行了口服拟交感神经药治疗效果的评估。在所评估的各项临床参数方面，拟交感神经药（特布他林）与安慰剂之间未发现显著差异。作者得出结论，该药在治疗慢性荨麻疹方面的疗效存疑。
